Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Neurology, Neurosurgery, and Psychiatry|December 26, 2006
Cerebral venous thrombosis and plasma concentrations of factor VIII and von Willebrand factor: a case control studyJean-Marc Bugnicourt, Bertrand Roussel, Blaise Tramier, et al.
Revue D'Histoire De La Pharmacie|April 26, 2003
[History of the therapeutic uses of the tinder polypore, Fomes fomentarius (L. : Fr]Bertrand Roussel, Sylvie Rapior, Colette Charlot, et al.
Clinical Neurology and Neurosurgery|December 15, 2010
Aspirin non-responder status and early neurological deterioration: a prospective studyJean-Marc Bugnicourt, Bertrand Roussel, Pierre-Yves Garcia, et al.
Therapie|June 23, 2005
[Assessment of the quality of oral anticoagulation management in patients admitted to Amiens University Hospital]Valérie Gras-Champel, Annelise Voyer, Céline Lematte, et al.
Medicine|December 31, 2015
Risk Factors for Bleeding in Hospitalized at Risk Patients With an INR of 5 or More Treated With Vitamin K AntagonistsSophie Liabeuf, Lucie-Marie Scaltieux, Kamel Masmoudi, et al.
American Journal of Therapeutics|June 15, 2006
Quality evaluation of the management of oral anticoagulation therapy (OAT): the awareness of treating physicians and the education of patients needs to be improvedValérie Gras-Champel, Annelise Voyer, Nicolas Guillaume, et al.
Frontiers in Neurology|November 25, 2021
Cerebral Venous Thrombosis: Clinical, Radiological, Biological, and Etiological Characteristics of a French Prospective Cohort (FPCCVT)-Comparison With ISCVT CohortAude Triquenot Bagan, Isabelle Crassard, Ludovic Drouet, et al.
Research and Practice in Thrombosis and Haemostasis|May 4, 2023
C-reactive protein and D-dimer in cerebral vein thrombosis: Relation to clinical and imaging characteristics as well as outcomes in a French cohort studyPaul Billoir, Virginie Siguret, Elisabeth Masson Fron, et al.
Pageof 1